Medicine guide
Jaypirca 50 mg
As listed in the register: Jaypirca 50 mg, comprimés pelliculés
50 mg ·
- Prescription only
- Cancer treatments and immune-system medicines
- Active substance
- Pirtobrutinibum
- Made by
- Eli Lilly (Suisse) SA
- Source
- Official label
Quoted from the official source. Not yet reviewed by Mediclarum — the leaflet in your pack is authoritative.
What it is for
- Mantelzelllymphom, chronische lymphatische Leukämie
From the official label · 2026-09-30 · Swissmedic
Details
| Made by | Eli Lilly (Suisse) SA |
|---|---|
| Active substance | Pirtobrutinibum |
| Used in | Cancer treatments and immune-system medicines |
| Strength | 50 mg |
| Classification | L01EL · Cancer treatments and immune-system medicines |
| Dispensing (as stated by the register) | Abgabekategorie A |
| Name in the register | Jaypirca 50 mg, comprimés pelliculés |
| Packs | 30 Tablette(n) · 28 Tablette(n) |
| Zulassungsnummer | 68733 |
| Dosisstärke | 1 |
Source: Zugelassene Packungen Humanarzneimittel · 2026-09-30 · not reviewed by a clinician
Quelle: Swissmedic. The publisher’s terms do not grant reproduction, so text is shortened and linked. Publisher’s terms.
Same active substance
These contain the same substance. That does not mean one can replace another — ask a pharmacist.